{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:57:47Z","timestamp":1765727867527},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,17]]},"DOI":"10.1093\/ajhp\/zxz032","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T05:03:00Z","timestamp":1555477380000},"page":"581-590","source":"Crossref","is-referenced-by-count":23,"title":["Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings"],"prefix":"10.1093","volume":"76","author":[{"given":"Haley J","family":"Appaneal","sequence":"first","affiliation":[{"name":"Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, and College of Pharmacy, University of Rhode Island, Kingston, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisling R","family":"Caffrey","sequence":"additional","affiliation":[{"name":"Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, and College of Pharmacy, University of Rhode Island, Kingston, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Beganovic","sequence":"additional","affiliation":[{"name":"Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, and College of Pharmacy, University of Rhode Island, Kingston, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"Avramovic","sequence":"additional","affiliation":[{"name":"Health Administration and Policy, George Mason University, Fairfax, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry L","family":"LaPlante","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, and College of Pharmacy, University of Rhode Island, Kingston, RI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"2019041701025502200_CIT0001","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2019041701025502200_CIT0002","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/cis356","article-title":"Predictors of first recurrence of Clostridium difficile infection: implications for initial management","volume":"55","author":"Eyre","year":"2012","journal-title":"Clin Infect Dis."},{"key":"2019041701025502200_CIT0003","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1017\/ice.2014.88","article-title":"Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis","volume":"36","author":"Deshpande","year":"2015","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2019041701025502200_CIT0004","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(05)70215-2","article-title":"Treatment of Clostridium difficile-associated disease: old therapies and new strategies","volume":"5","author":"Aslam","year":"2005","journal-title":"Lancet Infect Dis."},{"key":"2019041701025502200_CIT0005","doi-asserted-by":"crossref","first-page":"1178633718758023","DOI":"10.1177\/1178633718758023","article-title":"Recent progress for the effective prevention and treatment of recurrent Clostridium difficile infection","volume":"11","author":"Ramsay","year":"2018","journal-title":"Infect Dis (Auckl)."},{"issue":"Pt 2","key":"2019041701025502200_CIT0006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1099\/jmm.0.45753-0","article-title":"Alternative treatments for Clostridium difficile disease: what really works","volume":"54","author":"McFarland","year":"2005","journal-title":"J Med Microbiol."},{"key":"2019041701025502200_CIT0007","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jinf.2009.03.010","article-title":"Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes","volume":"58","author":"Johnson","year":"2009","journal-title":"J Infect."},{"key":"2019041701025502200_CIT0008","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"2019041701025502200_CIT0009","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.mayocp.2012.05.025","article-title":"Clostridium difficile infection in patients with chronic kidney disease","volume":"87","author":"Keddis","year":"2012","journal-title":"Mayo Clin Proc."},{"key":"2019041701025502200_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect."},{"key":"2019041701025502200_CIT0011","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhin.2008.08.012","article-title":"Meta-analysis to assess risk factors for recurrent Clostridium difficile infection","volume":"70","author":"Garey","year":"2008","journal-title":"J Hosp Infect."},{"key":"2019041701025502200_CIT0012","first-page":"1201","article-title":"Severe Clostridium difficile-associated disease in populations previously at low risk\u2014four states, 2005","volume":"54","author":"Centers for Disease C, Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2019041701025502200_CIT0013","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/597507","article-title":"Clostridium difficile infection in Ohio hospitals and nursing homes during 2006","volume":"30","author":"Campbell","year":"2009","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2019041701025502200_CIT0014","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ajg.2011.398","article-title":"The epidemiology of community-acquired Clostridium difficile infection: a population-based study","volume":"107","author":"Khanna","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"2019041701025502200_CIT0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1017\/ice.2015.102","article-title":"Identification of recurrent Clostridium difficile infection using administrative codes: accuracy and implications for surveillance","volume":"36","author":"Wen","year":"2015","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2019041701025502200_CIT0016","author":"National Center for Veterans Analysis and Statistics."},{"key":"2019041701025502200_CIT0017","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use","volume":"160","author":"Agha","year":"2000","journal-title":"Arch Intern Med."},{"key":"2019041701025502200_CIT0018","doi-asserted-by":"crossref","first-page":"e0189227","DOI":"10.1371\/journal.pone.0189227","article-title":"National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014","volume":"12","author":"Reveles","year":"2017","journal-title":"PLoS One."},{"key":"2019041701025502200_CIT0019","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajic.2013.08.009","article-title":"Recurrence of Clostridium difficile infection among Veterans with spinal cord injury and disorder","volume":"42","author":"Ramanathan","year":"2014","journal-title":"Am J Infect Control."},{"key":"2019041701025502200_CIT0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1017\/ice.2016.27","article-title":"Effect of a Clostridium difficile infection prevention initiative in Veterans Affairs acute care facilities","volume":"37","author":"Evans","year":"2016","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2019041701025502200_CIT0021","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/674851","article-title":"Comparison of 3 severity criteria for Clostridium difficile infection","volume":"35","author":"Gomez-Simmonds","year":"2014","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2019041701025502200_CIT0022","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2334-13-150","article-title":"Validation of the chronic disease score-infectious disease (CDS-ID) for the prediction of hospital-associated Clostridium difficile infection (CDI) within a retrospective cohort","volume":"13","author":"Stevens","year":"2013","journal-title":"BMC Infect Dis."},{"key":"2019041701025502200_CIT0023","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med."},{"key":"2019041701025502200_CIT0024","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"Aas","year":"2003","journal-title":"Clin Infect Dis."},{"key":"2019041701025502200_CIT0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect Dis."},{"key":"2019041701025502200_CIT0026","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med."},{"key":"2019041701025502200_CIT0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/1469-0691.12012","article-title":"Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"2019041701025502200_CIT0028","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ajic.2017.09.020","article-title":"Shift to community-onset Clostridium difficile infection in the national Veterans Health Administration, 2003-2014","volume":"46","author":"Reveles","year":"2018","journal-title":"Am J Infect Control."},{"key":"2019041701025502200_CIT0029","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IDR.S108325","article-title":"An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes","volume":"9","author":"Thabit","year":"2016","journal-title":"Infect Drug Resist."},{"key":"2019041701025502200_CIT0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamainternmed.2016.9045","article-title":"Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection","volume":"177","author":"Stevens","year":"2017","journal-title":"JAMA Intern Med."},{"key":"2019041701025502200_CIT0031","volume-title":"Clinical Classifications Software (CCS) for ICD-9-CM (March 2017).","author":"Healthcare Cost and Utilization Project (HCUP),"},{"key":"2019041701025502200_CIT0032","doi-asserted-by":"crossref","first-page":"e98400","DOI":"10.1371\/journal.pone.0098400","article-title":"Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review","volume":"9","author":"Abou Chakra","year":"2014","journal-title":"PLoS One."},{"key":"2019041701025502200_CIT0033","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"Hosmer","year":"2000"},{"key":"2019041701025502200_CIT0034","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/phar.2088","article-title":"Derivation and validation of a Clostridium difficile infection recurrence prediction rule in a national cohort of Veterans","volume":"38","author":"Reveles","year":"2018","journal-title":"Pharmacotherapy."},{"key":"2019041701025502200_CIT0035","doi-asserted-by":"crossref","first-page":"e46966","DOI":"10.1371\/journal.pone.0046966","article-title":"Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile","volume":"7","author":"Peterfreund","year":"2012","journal-title":"PLoS One."},{"key":"2019041701025502200_CIT0036","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/cid\/civ140","article-title":"Current trends in the epidemiology and outcomes of Clostridium difficile infection","volume":"60","author":"Evans","year":"2015","journal-title":"Clin Infect Dis."},{"key":"2019041701025502200_CIT0037","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"2019041701025502200_CIT0038","doi-asserted-by":"crossref","first-page":"e56498","DOI":"10.1371\/journal.pone.0056498","article-title":"The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis","volume":"8","author":"Tleyjeh","year":"2013","journal-title":"PLoS One."},{"key":"2019041701025502200_CIT0039","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"2019041701025502200_CIT0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2016.03.008","article-title":"Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis","volume":"48","author":"Vardakas","year":"2016","journal-title":"Int J Antimicrob Agents."},{"key":"2019041701025502200_CIT0041","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"2019041701025502200_CIT0042","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00337-18","article-title":"Prevalence of inappropriate antibiotic prescribing in primary care clinics within a Veterans Affairs health care system","volume":"62:","author":"Shively","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"2019041701025502200_CIT0043","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/cis457","article-title":"Does doxycycline protect against development of Clostridium difficile infection","volume":"55","author":"Doernberg","year":"2012","journal-title":"Clin Infect Dis."},{"key":"2019041701025502200_CIT0044","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anaerobe.2015.04.012","article-title":"Recurrent Clostridium difficile infection: from colonization to cure","volume":"34","author":"Shields","year":"2015","journal-title":"Anaerobe."},{"key":"2019041701025502200_CIT0045","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","article-title":"A randomized placebo-controlled trial of saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease","volume":"271","author":"McFarland","year":"1994","journal-title":"JAMA."},{"key":"2019041701025502200_CIT0046","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0002-9270(99)00809-6","article-title":"The effect of probiotics on Clostridium difficile diarrhea","volume":"95","author":"Pochapin","year":"2000","journal-title":"Am J Gastroenterol."},{"key":"2019041701025502200_CIT0047","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1099\/jmm.0.46096-0","article-title":"Probiotics for recurrent Clostridium difficile disease","volume":"54","author":"Lawrence","year":"2005","journal-title":"J Med Microbiol."},{"key":"2019041701025502200_CIT0048","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/658944","article-title":"Development and validation of a Clostridium difficile infection risk prediction model","volume":"32","author":"Dubberke","year":"2011","journal-title":"Infect Control Hosp Epidemiol."},{"key":"2019041701025502200_CIT0049","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/JCM.03352-12","article-title":"Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain","volume":"51","author":"Rodr\u00edguez-Pardo","year":"2013","journal-title":"J Clin Microbiol."},{"issue":"9","key":"2019041701025502200_CIT0050","first-page":"CD004610","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhea in adults","author":"Nelson","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"2019041701025502200_CIT0051","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpgasthep1029","article-title":"Update on the changing epidemiology of Clostridium difficile-associated disease","volume":"5","author":"McFarland","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol."},{"key":"2019041701025502200_CIT0052","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/521863","article-title":"Clinical recognition and diagnosis of Clostridium difficile infection","volume":"46","author":"Bartlett","year":"2008","journal-title":"Clin Infect Dis."},{"key":"2019041701025502200_CIT0053","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.3748\/wjg.v20.i23.7416","article-title":"Recurrent Clostridium difficile infections: the importance of the intestinal microbiota","volume":"20","author":"Zanella Terrier","year":"2014","journal-title":"World J Gastroenterol."},{"key":"2019041701025502200_CIT0054","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1469-0691.12046","article-title":"Can we identify patients at high risk of recurrent Clostridium difficile infection","volume":"18","author":"Kelly","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"2019041701025502200_CIT0055","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1310\/hpj5011-1003","article-title":"Risk factors for recurrent Clostridium difficile infections and strategies to decrease readmissions in a community hospital","volume":"50","author":"Majors","year":"2015","journal-title":"Hosp Pharm."},{"key":"2019041701025502200_CIT0056","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/003335491212700107","article-title":"Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008","volume":"127","author":"VerLee","year":"2012","journal-title":"Public Health Rep."},{"key":"2019041701025502200_CIT0057","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archsurg.142.7.624","article-title":"Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States","volume":"142","author":"Ricciardi","year":"2007","journal-title":"Arch Surg."},{"key":"2019041701025502200_CIT0058","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"2019041701025502200_CIT0059","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S1473-3099(18)30285-8","article-title":"Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis","volume":"18","author":"Beinortas","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"2019041701025502200_CIT0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials","volume":"59","author":"Johnson","year":"2014","journal-title":"Clin Infect Dis."},{"key":"2019041701025502200_CIT0061","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cmi.2017.12.022","article-title":"Update of treatment algorithms for Clostridium difficile infection","volume":"24","author":"Ooijevaar","year":"2018","journal-title":"Clin Microbiol Infect."},{"key":"2019041701025502200_CIT0062","first-page":"CD004610","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults","volume":"(3)","author":"Nelson","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"2019041701025502200_CIT0063","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis."},{"key":"2019041701025502200_CIT0064","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jhm.2330","article-title":"Reduction of inappropriate exit prescriptions for proton pump inhibitors: a before-after study using education paired with a web-based quality-improvement tool","volume":"10","author":"McDonald","year":"2015","journal-title":"J Hosp Med."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/76\/9\/581\/28441926\/zxz032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T05:03:13Z","timestamp":1555477393000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/76\/9\/581\/5466523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":64,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,4,17]]},"published-print":{"date-parts":[[2019,4,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxz032","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5,1]]},"published":{"date-parts":[[2019,4,17]]}}}